ENLV · Enlivex Therapeutics Ltd.

Enlivex's partnership with Ondo Finance introduces ENLVon, broadening access to its shares for non-U.S. investors via tokenized digital assets. This leverages Ondo's dominant position in the tokenized stock market, which has exceeded $1 billion in on-chain value, with Ondo commanding over 61% share and $653 million tokenized. The initiative supports low-minimum fractional investments, wallet-based holding, transfers under regulatory rules, and integration into DeFi applications like collateralized lending. CEO Oren Hershkovitz emphasized this as an extension of Enlivex's innovation strategy, targeting digitally native investors familiar with its prediction markets treasury and Allocetra immunotherapy for age-related osteoarthritis. While forward-looking statements highlight potential benefits for liquidity and visibility, risks include uncertain adoption, digital asset infrastructure issues, and regulatory hurdles for tokenized securities.